Health Care | Health Care Equipment & Services | Health Care Technology
NASDAQ | Common Stock
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States.
The company operates in two segments, CareVention HealthCare and MedWise HealthCare.
It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention.
The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting.
In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services.
As of December 31, 2022, it served approximately 150 healthcare organizations.
The company provides cloud-based software applications to assist prescribers and pharmacists.
Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 23 | 0.03 Increased by +112.00% | -0.12 Increased by +125.00% |
| May 8, 23 | -0.02 Increased by +90.91% | -0.14 Increased by +85.71% |
| Mar 6, 23 | -0.05 Increased by +44.44% | -0.06 Increased by +16.67% |
| Nov 3, 22 | -0.26 Decreased by -550.00% | -0.11 Decreased by -136.36% |
| Aug 4, 22 | -0.25 Decreased by -2.40 K% | -0.12 Decreased by -108.33% |
| May 5, 22 | -0.22 Decreased by -144.44% | -0.16 Decreased by -37.50% |
| Feb 24, 22 | -0.09 Decreased by -12.50% | -0.08 Decreased by -12.50% |
| Nov 4, 21 | -0.04 Decreased by -300.00% | 0.03 Decreased by -233.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 23 | 90.04 M Increased by +24.02% | -9.85 M Increased by +22.38% | Decreased by -10.94% Increased by +37.41% |
| Mar 31, 23 | 88.28 M Increased by +31.54% | -7.07 M Increased by +74.91% | Decreased by -8.01% Increased by +80.93% |
| Dec 31, 22 | 82.71 M Decreased by -3.47% | -18.37 M Increased by +14.04% | Decreased by -22.21% Increased by +10.94% |
| Sep 30, 22 | 77.10 M Decreased by -10.95% | -25.88 M Decreased by -51.25% | Decreased by -33.57% Decreased by -69.85% |
| Jun 30, 22 | 72.60 M Decreased by -11.80% | -12.69 M Increased by +39.80% | Decreased by -17.48% Increased by +31.75% |
| Mar 31, 22 | 67.11 M Decreased by -12.48% | -28.19 M Decreased by -44.64% | Decreased by -42.01% Decreased by -65.26% |
| Dec 31, 21 | 85.69 M Increased by +11.20% | -21.37 M Increased by +30.23% | Decreased by -24.94% Increased by +37.26% |
| Sep 30, 21 | 86.59 M Increased by +22.81% | -17.11 M Increased by +20.74% | Decreased by -19.76% Increased by +35.46% |